Business · 29/05/2025
FDA Classifies Inherited Nucleotide Repeat Disorder DNA Test into Class II Special Controls
The FDA has classified the inherited nucleotide repeat disorder DNA test into Class II special controls, aiming to provide a reasonable assurance of safety and effectiveness while reducing regulatory burdens and enhancing patients' access to innovative devices.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →